Increased scalp skin lipids in response to antidandruff treatment containing zinc pyrithione.
Rogers
J S
JS
Unilever R & D Colworth, Sharnbrook, MK44 1LQ, UK. Julia.S.Rogers@unilever.com
Moore
A E
AE
Meldrum
H
H
Harding
C R
CR
D002518:Ceramides / Q000378:metabolism; D003881:Dermatomycoses / Q000188:drug therapy* / Q000378:metabolism*; D004817:Epidermis / Q000378:metabolism; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use*; D050356:Lipid Metabolism; D008290:Malassezia; D009942:Organometallic Compounds / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D012535:Scalp / Q000378:metabolism*
D002518:Ceramides; D007641:Keratolytic Agents; D009942:Organometallic Compounds; D011725:Pyridines; C010423:pyrithione zinc